Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Denosumab PFS vs Vial in Low BMD
NCT00515463Phase 3Completed
- Sponsor
- Amgen
- Start
- May 2007
- Primary completion
- Mar 2008
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
01
Overview
A Phase 3 trial of denosumab in osteopenia, osteoporosis, sponsored by Amgen. Started May 2007; status: completed.
02
Drugs
denosumab
03
Conditions
osteopeniaosteoporosis
Beyond the preview
Go deeper on NCT00515463.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00515463.